Publikationen

Friedrich Kommoss, Stefan Kommoss, Dietmar Schmidt, Marcus J Trunk, Jacobus Pfisterer, Andreas du Bois: Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecologic Oncology 05/2005; 97(1). DOI:10.1016/j.ygyno.2004.12.047

L.-C. Horn, J. Einenkel, M. Höckel, H. Kölbl, F. Kommoss, S. F. Lax, L. Riethdorf, H.-G. Schnürch, D. Schmidt: Pathologisch-anatomische Aufarbeitung und Befundung von Lymphknoten bei gynäkologischen Malignomen. Der Pathologe 07/2005; 26(4). DOI:10.1007/s00292-005-0764-3

D. Schmidt, L.-C. Horn, F. Kommoss: Histopathologie des Plattenepithelkarzinoms und des Adenokarzinoms der Cervix uteri. Der Pathologe 07/2005; 26(4). DOI:10.1007/s00292-005-0765-2

Dietmar Schmidt: Cervical carcinoma. Current aspects of diagnosis and therapy. Der Pathologe 08/2005; 26(4). DOI:10.1007/s00292-005-0770-5

D Schmidt, L-C Horn, F Kommoss: Neuroendocrine carcinomas of the cervix. Der Pathologe 08/2005; 26(4). DOI:10.1007/s00292-005-0766-1

D Schmidt, L-C Horn, F Kommoss: [Histopathology of squamous cell carcinoma and adenocarcinoma of the uterine cervix].. Der Pathologe 08/2005; 26(4).

L-C Horn, J Einenkel, M Höckel, H Kölbl, F Kommoss, S F Lax, L Riethdorf, H-G Schnürch, D Schmidt: [Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies].. Der Pathologe 08/2005; 26(4).

Park TW, Theuerkauf I, Morakkabati N (2005) Orbital metastases of unknown origin: HPV typing identifies the primary tumor. Acta Obstet Gynecol Scand 84:702-4

Grabellus F, Worm K, Willruth A, Schmitz KJ, Otterbach F, Baba HA, Kimmig R, Metz KA. ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual. Breast. 2005 Feb;14(1):71-4.

Schmitz KJ, Grabellus F, Callies R, Otterbach F, Wohlschlaeger J, Levkau B, Kimmig R, Schmid KW, Baba HA. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res. 2005;7(2):R194-203. Epub 2005 Jan 7.